Benzinga | Jul 20, 2021 12:10PM EDT

SVB Leerink Maintains Market Perform on Abbott Laboratories, Raises Price Target to $128

SVB Leerink analyst Danielle Antalffy maintains Abbott Laboratories (NYSE:ABT) with a Market Perform and raises the price target from $115 to $128.